Reply to Commentary on "Pulse Oximetry Screening for Critical Congenital Heart Defects"

Andrew K Ewer¹, Shakila Thangaratinam², Nieves Plana^{3

4}, Javier Zamora^{2

4}

Affiliations

¹ Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom, a.k.ewer@bham.ac.uk.
² Barts and the London School of Medicine and Dentistry and Queen Mary University of London, London, United Kingdom.
³ Preventive Medicine Department, Principe de Asturias Hospital, Alcala de Henares, Spain.
⁴ Clinical Biostatistics Unit, Ramón y Cajal Hospital (IRYCIS), Madrid, Spain.

Comment

Andrew K Ewer et al. Neonatology. 2019.

. 2019;116(4):390-391.

doi: 10.1159/000502015. Epub 2019 Aug 27.

Andrew K Ewer¹, Shakila Thangaratinam², Nieves Plana^{3

4}, Javier Zamora^{2

4}

¹ Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom, a.k.ewer@bham.ac.uk.
² Barts and the London School of Medicine and Dentistry and Queen Mary University of London, London, United Kingdom.
³ Preventive Medicine Department, Principe de Asturias Hospital, Alcala de Henares, Spain.
⁴ Clinical Biostatistics Unit, Ramón y Cajal Hospital (IRYCIS), Madrid, Spain.

No abstract available

Comment in

Response to the Letter "RE: Commentary on 'Pulse Oximetry Screening for Critical Congenital Heart Defects'".
Oddie S, McGuire W. Oddie S, et al. Neonatology. 2019;116(4):392. doi: 10.1159/000502014. Epub 2019 Aug 30. Neonatology. 2019. PMID: 31473740 No abstract available.

Commentary on "Pulse Oximetry Screening for Critical Congenital Heart Defects".
Oddie S, McGuire W. Oddie S, et al. Neonatology. 2020;117(1):4-7. doi: 10.1159/000496621. Epub 2019 May 27. Neonatology. 2020. PMID: 31132770 No abstract available.